Identifying the Predictors of Pediatric Vaccine Uptake during the COVID-19 Pandemic
Abstract
:1. Introduction
2. Methods
2.1. Participants and Procedures
2.2. Measures
3. Results
3.1. Descriptive Results
3.2. COVID-19-Vaccine, General Vaccine, and COVID-19 Knowledge for Parents of Children 17 and Under
3.3. Education vs. COVID-19 Vaccination
3.4. Political Affiliation vs. COVID-19 Vaccination
3.5. Race vs. COVID-19 Vaccination
3.6. Predictors of Routine Childhood Vaccination Acceptance by Expectant Parents
3.7. Predictors of COVID-19 Vaccine Acceptance for Parents of Children 17 and Under
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- World Health Organization. Who Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020; World Health Organization: Geneva, Switzerland, 2020; Available online: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed on 13 April 2022).
- Centers for Disease Control and Prevention. COVID-19 Data Tracker. 2022. Available online: https://covid.cdc.gov/covid-data-tracker/#datatracker-home (accessed on 6 December 2022).
- Travis, J.; Harris, S.; Fadel, T.; Webb, G. Identifying the determinants of COVID-19 preventative behaviors and vaccine intentions among South Carolina residents. PLoS ONE 2021, 16, e0256178. [Google Scholar] [CrossRef] [PubMed]
- Pfizer. BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older. 2021. Available online: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-biontech-covid-19-vaccine-comirnatyr-receives-full (accessed on 6 December 2022).
- Johnson, J. Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use—First Single-Shot Vaccine in Fight Against Global Pandemic. 2021. Available online: https://www.jnj.com/media-center/press-releases/johnson-johnson-covid-19-vaccine-authorized-by-u-s-fda-for-emergency-usefirst-single-shot-vaccine-in-fight-against-global-pandemic#:~:text=NEW%20BRUNSWICK%2C%20N.J.%2C%20February%2027,of%20Johnson%20%26%20Johnson%2C%20to%20prevent (accessed on 6 December 2022).
- Johnson, J. Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 Years and Older Vaccine Demonstrates p. Johnson & Johnson. 2021. Available online: https://www.jnj.com/media-center/press-releases/johnson-johnson-covid-19-vaccine-fully-approved-by-health-canada-to-prevent-covid-19-in-individuals-18-years-and-older (accessed on 6 December 2022).
- Ledford, H. Moderna COVID vaccine becomes second to get US authorization. Nature, 2020; online ahead of print. [Google Scholar] [CrossRef]
- Wallace, M. The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines—United States, February 2022. MMWR Morb. Mortal. Wkly. Rep. 2022, 71, 416–421. [Google Scholar] [PubMed]
- United States Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-Biontech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight against Pandemic; United States Food and Drug Administration: Silver Spring, MD, USA, 2021. [Google Scholar]
- United States Food and Drug Administration. FDA Authorizes Pfizer-Biontech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age. 2021. Available online: https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age#:~:text=Years%20of%20Age-,FDA%20Authorizes%20Pfizer%2DBioNTech%20COVID%2D19%20Vaccine%20for%20Emergency%20Use,through%2011%20Years%20of%20Age&text=Today%2C%20the%20U.S.%20Food%20and,through%2011%20years%20of%20age (accessed on 6 December 2022).
- South Carolina Department of Health and Environmental Control. Coronavirus Disease 2019. 2022. Available online: https://scdhec.gov/covid19/covid-19-data/#viz1651519321236 (accessed on 6 December 2022).
- Schneider, K.E.; Dayton, L.; Rouhani, S.; Latkin, C.A. Implications of attitudes and beliefs about COVID-19 vaccines for vaccination campaigns in the United States: A latent class analysis. Prev. Med. Rep. 2021, 24, 101584. [Google Scholar] [CrossRef] [PubMed]
- Chanchlani, N.; Buchanan, F.; Gill, P.J. Addressing the indirect effects of COVID-19 on the health of children and young people. CMAJ 2020, 192, E921–E927. [Google Scholar] [CrossRef] [PubMed]
- He, K.; Mack, W.J.; Neely, M.; Lewis, L.; Anand, V. Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy. J. Community Health 2022, 47, 39–52. [Google Scholar] [CrossRef] [PubMed]
- South Carolina Department of Health and Environmental Control. South Carolina Immunization Data. 2022. Available online: https://scdhec.gov/health/vaccinations/sc-immunization-data (accessed on 6 December 2022).
- Sznajder, K.K.; Kjerulff, K.H.; Wang, M.; Hwang, W.; Ramirez, S.I.; Gandhi, C.K. COVID-19 vaccine acceptance and associated factors among pregnant women in Pennsylvania 2020. Prev. Med. Rep. 2022, 26, 101713. [Google Scholar] [CrossRef] [PubMed]
- Rocha, Y.M.; de Moura, G.A.; Desidério, G.A.; de Oliveira, C.H.; Lourenço, F.D.; de Figueiredo Nicolete, L.D. The impact of fake news on social media and its influence on health during the COVID-19 pandemic: A systematic review. J. Public Health 2021, 31, 1007–1016. [Google Scholar] [CrossRef] [PubMed]
- Teasdale, C.A.; Borrell, L.N.; Kimball, S.; Rinke, M.L.; Rane, M.; Fleary, S.A.; Nash, D. Plans to Vaccinate Children for Coronavirus Disease 2019: A Survey of United States Parents. J. Pediatr. 2021, 237, 292–297. [Google Scholar] [CrossRef] [PubMed]
- Khairat, S.; Zou, B.; Adler-Milstein, J. Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the US. Am. J. Infect. Control 2022, 50, 262–267. [Google Scholar] [CrossRef] [PubMed]
- Smith, W. Does Gender Influence Online Survey Participation? A Record-Linkage Analysis of University Faculty Online Survey Response Behavior. Online Submission. 2008. Available online: https://eric.ed.gov/?id=ED501717 (accessed on 6 December 2022).
- Matoff-Stepp, S.; Applebaum, B.; Pooler, J.; Kavanagh, E. Women as health care decision-makers: Implications for health care coverage in the United States. J. Health Care Poor Underserved 2014, 25, 1507–1513. [Google Scholar] [CrossRef] [PubMed]
- Reich, J.A. Neoliberal Mothering and Vaccine Refusal: Imagined Gated Communities and the Privilege of Choice. Gend. Soc. 2014, 28, 679–704. [Google Scholar] [CrossRef]
- McElfish, P.A.; Willis, D.E.; Shah, S.K.; Bryant-Moore, K.; Rojo, M.O.; Selig, J.P. Sociodemographic Determinants of COVID-19 Vaccine Hesitancy, Fear of Infection, and Protection Self-Efficacy. J. Prim. Care Community Health 2021, 12, 21501327211040746. [Google Scholar] [CrossRef] [PubMed]
- Okubo, R.; Yoshioka, T.; Ohfuji, S.; Matsuo, T.; Tabuchi, T. COVID-19 Vaccine Hesitancy and Its Associated Factors in Japan. Vaccines 2021, 9, 662. [Google Scholar] [CrossRef] [PubMed]
- Albrecht, D. Vaccination, politics and COVID-19 impacts. BMC Public Health 2022, 22, 96. [Google Scholar] [CrossRef] [PubMed]
- Bagasra, A.B.; Doan, S.; Allen, C.T. Racial differences in institutional trust and COVID-19 vaccine hesitancy and refusal. BMC Public Health 2021, 21, 2104. [Google Scholar] [CrossRef] [PubMed]
- Hill, L.; Artiga, S. COVID-19 Cases and Deaths by Race/Ethnicity: Current Data and Changes over Time. 2022. Available online: https://www.kff.org/coronavirus-covid-19/issue-brief/covid-19-cases-and-deaths-by-race-ethnicity-current-data-and-changes-over-time/ (accessed on 9 May 2022).
- Stroebe, W.; Vandellen, M.R.; Abakoumkin, G.; Lemay, E.P., Jr.; Schiavone, W.M.; Agostini, M.; Bélanger, J.J.; Gützkow, B.; Kreienkamp, J.; Reitsema, A.M.; et al. Politicization of COVID-19 health-protective behaviors in the United States: Longitudinal and cross-national evidence. PLoS ONE 2021, 16, e0256740. [Google Scholar] [CrossRef] [PubMed]
- Qualtrics. What Is Response Bias and How Can You Avoid It? Qualtrics: Seattle, WA, USA, 2022; Available online: https://www.qualtrics.com/experience-management/research/response-bias/ (accessed on 6 June 2022).
- Seither, R. Vaccination Coverage with Selected Vaccines and Exemption Rates among Children in Kindergarten—United States, 2020–2021 School Year. MMWR Morb. Mortal. Wkly. Rep. 2022, 71, 561–568. [Google Scholar] [CrossRef] [PubMed]
- Liang, H.; Fung, I.C.; Tse, Z.T.; Yin, J.; Chan, C.H.; Pechta, L.E.; Smith, B.J.; Marquez-Lameda, R.D.; Meltzer, M.I.; Lubell, K.M.; et al. How did Ebola information spread on twitter: Broadcasting or viral spreading? BMC Public Health 2019, 19, 438. [Google Scholar] [CrossRef] [PubMed]
B | SE | p | Odds Ratio | 95% Confidence Interval for Odds Ratio | |||
---|---|---|---|---|---|---|---|
Lower Bound | Upper Bound | ||||||
No | Intercept | −0.186 | 1.353 | 0.890 | |||
Age | 0.062 | 0.026 | 0.020 | 1.064 | 1.010 | 1.120 | |
Education Level | −0.264 | 0.190 | 0.164 | 0.768 | 0.529 | 1.114 | |
COVID-19-Vaccine Knowledge | 0.101 | 0.142 | 0.478 | 1.106 | 0.837 | 1.461 | |
General Vaccine Knowledge | −0.060 | 0.218 | 0.784 | 0.942 | 0.614 | 1.445 | |
COVID-19 Knowledge | −0.246 | 0.114 | 0.030 | 0.782 | 0.626 | 0.977 | |
Race (White) | −0.110 | 0.546 | 0.840 | 0.896 | 0.307 | 2.609 | |
Gender (Male) | −0.941 | 0.478 | 0.049 | 0.390 | 0.153 | 0.997 | |
Political Affiliation (Democrat) | 0.193 | 0.498 | 0.699 | 1.213 | 0.457 | 3.221 | |
Unsure | Intercept | −1.786 | 2.064 | 0.387 | |||
Age | 0.013 | 0.038 | 0.733 | 1.013 | 0.940 | 1.092 | |
Education Level | −0.019 | 0.256 | 0.941 | 0.981 | 0.594 | 1.622 | |
COVID-19-Vaccine Knowledge | 0.039 | 0.194 | 0.842 | 1.040 | 0.710 | 1.522 | |
General Vaccine Knowledge | 0.017 | 0.325 | 0.959 | 1.017 | 0.538 | 1.921 | |
COVID-19 Knowledge | 0.060 | 0.175 | 0.734 | 1.061 | 0.753 | 1.496 | |
Race (White) | −0.941 | 0.729 | 0.197 | 0.390 | 0.093 | 1.628 | |
Gender (Male) | −1.511 | 0.866 | 0.081 | 0.221 | 0.040 | 1.206 | |
Political Affiliation (Democrat) | −0.234 | 0.723 | 0.746 | 0.791 | 0.192 | 3.261 |
B | SE | p | Odds Ratio | 95% Confidence Interval for Odds Ratio | |||
---|---|---|---|---|---|---|---|
Lower Bound | Upper Bound | ||||||
No | Intercept | 6.67 | 1.12 | <0.001 | |||
Age | −0.04 | 0.02 | 0.022 | 0.96 | 0.93 | 0.99 | |
Education Level | −0.288 | 0.12 | 0.016 | 0.75 | 0.59 | 0.95 | |
COVID-19-Vaccine Knowledge | −0.37 | 0.11 | <0.001 | 0.69 | 0.56 | 0.85 | |
General Vaccine Knowledge | −0.716 | 0.18 | <0.001 | 0.49 | 0.34 | 0.70 | |
COVID-19 Knowledge | 0.166 | 0.09 | 0.061 | 1.18 | 0.99 | 1.41 | |
Race (White) | 0.217 | 0.42 | 0.602 | 1.24 | 0.55 | 2.81 | |
Gender (Male) | −1.709 | 0.39 | <0.001 | 0.18 | 0.09 | 0.39 | |
Political Affiliation (Democrat) | −1.507 | 0.36 | <0.001 | 0.22 | 0.11 | 0.45 | |
Unsure | Intercept | 2.317 | 1.21 | 0.056 | |||
Age | −0.012 | 0.02 | 0.473 | 0.99 | 0.96 | 1.02 | |
Education Level | −0.361 | 0.13 | 0.004 | 0.70 | 0.54 | 0.89 | |
COVID-19-Vaccine Knowledge | −0.192 | 0.11 | 0.083 | 0.83 | 0.66 | 1.03 | |
General Vaccine Knowledge | −0.215 | 0.20 | 0.277 | 0.81 | 0.55 | 1.19 | |
COVID-19 Knowledge | 0.281 | 0.10 | 0.006 | 1.32 | 1.08 | 1.62 | |
Race (White) | −0.744 | 0.42 | 0.074 | 0.48 | 0.21 | 1.08 | |
Gender (Male) | −1.096 | 0.39 | 0.005 | 0.33 | 0.16 | 0.72 | |
Political Affiliation (Democrat) | −1.469 | 0.39 | <0.001 | 0.23 | 0.11 | 0.49 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Phan, C.; Mercado, B.; Travis, J.; Webb, G. Identifying the Predictors of Pediatric Vaccine Uptake during the COVID-19 Pandemic. COVID 2024, 4, 495-505. https://doi.org/10.3390/covid4040033
Phan C, Mercado B, Travis J, Webb G. Identifying the Predictors of Pediatric Vaccine Uptake during the COVID-19 Pandemic. COVID. 2024; 4(4):495-505. https://doi.org/10.3390/covid4040033
Chicago/Turabian StylePhan, Colleen, Brandon Mercado, Justin Travis, and Ginny Webb. 2024. "Identifying the Predictors of Pediatric Vaccine Uptake during the COVID-19 Pandemic" COVID 4, no. 4: 495-505. https://doi.org/10.3390/covid4040033
APA StylePhan, C., Mercado, B., Travis, J., & Webb, G. (2024). Identifying the Predictors of Pediatric Vaccine Uptake during the COVID-19 Pandemic. COVID, 4(4), 495-505. https://doi.org/10.3390/covid4040033